9:41 AM
Leo Group India
| ||
| Ahead of the Bell: Onyx Pharmaceuticals Businessweek NEW YORK (AP) — Shares of Onyx Pharmaceuticals surged before Monday's opening bell on news that the company received an unsolicited takeover bid from Amgen Inc. The drug developer confirmed Sunday that it received an offer of $120 per share, but ... See all stories on this topic » | ||
| Covidien completes spinoff of pharmaceuticals unit Businessweek NEW YORK (AP) — Healthcare products company Covidien has completed the spinoff of its pharmaceuticals business, Mallinckrodt, into a separate publicly traded company. Ireland's Covidien PLC announced the planned spinoff in December 2011. See all stories on this topic » | ||
| Onyx Pharma Rejects Buyout Offer From Amgen CNBC.com Onyx Pharma Rejects Buyout Offer From Amgen. Text Size. Published: Sunday, 30 Jun 2013 | 2:06 PM ET. AP. Onyx Pharmaceuticals Inc on Sunday confirmed it had rejected an offer from Amgen Inc to buy the company in a deal valued at about $10 billion. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment